155 related articles for article (PubMed ID: 11280797)
21. ERF, an ETS-related transcriptional repressor, can induce erythroid differentiation.
Athanasiou M; Blair DG; Mavrothalassitis G
Anticancer Res; 2003; 23(3A):2143-53. PubMed ID: 12894589
[TBL] [Abstract][Full Text] [Related]
22. "Oncogenes as probes for cellular signal processes: the family of ETS genes".
Papas TS
AIDS Res Hum Retroviruses; 1992 May; 8(5):824-33. PubMed ID: 1515233
[No Abstract] [Full Text] [Related]
23. ESX induces transformation and functional epithelial to mesenchymal transition in MCF-12A mammary epithelial cells.
Schedin PJ; Eckel-Mahan KL; McDaniel SM; Prescott JD; Brodsky KS; Tentler JJ; Gutierrez-Hartmann A
Oncogene; 2004 Mar; 23(9):1766-79. PubMed ID: 14767472
[TBL] [Abstract][Full Text] [Related]
24. Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway.
Maida Y; Kyo S; Kanaya T; Wang Z; Yatabe N; Tanaka M; Nakamura M; Ohmichi M; Gotoh N; Murakami S; Inoue M
Oncogene; 2002 Jun; 21(26):4071-9. PubMed ID: 12037663
[TBL] [Abstract][Full Text] [Related]
25. Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo.
Battista S; de Nigris F; Fedele M; Chiappetta G; Scala S; Vallone D; Pierantoni GM; Mega T; Santoro M; Viglietto G; Verde P; Fusco A
Oncogene; 1998 Jul; 17(3):377-85. PubMed ID: 9690519
[TBL] [Abstract][Full Text] [Related]
26. Role of transcription factor Ets-1 in the apoptosis of human vascular endothelial cells.
Teruyama K; Abe M; Nakano T; Iwasaka-Yagi C; Takahashi S; Yamada S; Sato Y
J Cell Physiol; 2001 Aug; 188(2):243-52. PubMed ID: 11424091
[TBL] [Abstract][Full Text] [Related]
27. Invasive carcinomas dismantle surrounding stroma induced to express the nuclear factor c-ets-1.
Stehelin D
Princess Takamatsu Symp; 1994; 24():171-86. PubMed ID: 8983074
[No Abstract] [Full Text] [Related]
28. Expression of the ets-1 proto-oncogene in human colorectal carcinoma.
Nakayama T; Ito M; Ohtsuru A; Naito S; Sekine I
Mod Pathol; 2001 May; 14(5):415-22. PubMed ID: 11353051
[TBL] [Abstract][Full Text] [Related]
29. beta-Neuregulin and autocrine mediated survival of Schwann cells requires activity of Ets family transcription factors.
Parkinson DB; Langner K; Namini SS; Jessen KR; Mirsky R
Mol Cell Neurosci; 2002 May; 20(1):154-67. PubMed ID: 12056846
[TBL] [Abstract][Full Text] [Related]
30. In vivo complex formation of PU.1 with HDAC1 associated with PU.1-mediated transcriptional repression.
Kihara-Negishi F; Yamamoto H; Suzuki M; Yamada T; Sakurai T; Tamura T; Oikawa T
Oncogene; 2001 Sep; 20(42):6039-47. PubMed ID: 11593411
[TBL] [Abstract][Full Text] [Related]
31. Trans-activation of heparanase promoter by ETS transcription factors.
Lu WC; Liu YN; Kang BB; Chen JH
Oncogene; 2003 Feb; 22(6):919-23. PubMed ID: 12584571
[TBL] [Abstract][Full Text] [Related]
32. Mef2c is activated directly by Ets transcription factors through an evolutionarily conserved endothelial cell-specific enhancer.
De Val S; Anderson JP; Heidt AB; Khiem D; Xu SM; Black BL
Dev Biol; 2004 Nov; 275(2):424-34. PubMed ID: 15501228
[TBL] [Abstract][Full Text] [Related]
33. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R
Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377
[TBL] [Abstract][Full Text] [Related]
34. FEV acts as a transcriptional repressor through its DNA-binding ETS domain and alanine-rich domain.
Maurer P; T'Sas F; Coutte L; Callens N; Brenner C; Van Lint C; de Launoit Y; Baert JL
Oncogene; 2003 May; 22(21):3319-29. PubMed ID: 12761502
[TBL] [Abstract][Full Text] [Related]
35. Transcription factor-mediated proliferation and apoptosis in benign and malignant thyroid lesions.
Letsas KP; Frangou-Lazaridis M; Skyrlas A; Tsatsoulis A; Malamou-Mitsi V
Pathol Int; 2005 Nov; 55(11):694-702. PubMed ID: 16271081
[TBL] [Abstract][Full Text] [Related]
36. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia induces transcription factor ETS-1 via the activity of hypoxia-inducible factor-1.
Oikawa M; Abe M; Kurosawa H; Hida W; Shirato K; Sato Y
Biochem Biophys Res Commun; 2001 Nov; 289(1):39-43. PubMed ID: 11708773
[TBL] [Abstract][Full Text] [Related]
38. Transformation of thyroid epithelium is associated with loss of c-kit receptor.
Natali PG; Berlingieri MT; Nicotra MR; Fusco A; Santoro E; Bigotti A; Vecchio G
Cancer Res; 1995 Apr; 55(8):1787-91. PubMed ID: 7536131
[TBL] [Abstract][Full Text] [Related]
39. Induction of apoptosis by Elk-1 and deltaElk-1 proteins.
Shao N; Chai Y; Cui JQ; Wang N; Aysola K; Reddy ES; Rao VN
Oncogene; 1998 Jul; 17(4):527-32. PubMed ID: 9696047
[TBL] [Abstract][Full Text] [Related]
40. Nucleophosmin is overexpressed in thyroid tumors.
Pianta A; Puppin C; Franzoni A; Fabbro D; Di Loreto C; Bulotta S; Deganuto M; Paron I; Tell G; Puxeddu E; Filetti S; Russo D; Damante G
Biochem Biophys Res Commun; 2010 Jul; 397(3):499-504. PubMed ID: 20515654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
